Metastatic Prostate Cancer with a Testicular Mass: Rare Metastasis or Unexpected Primary Germ Cell Tumor?
DOI:
https://doi.org/10.24915/apuj.282Keywords:
Lymphatic Metastasis, Neoplasms, Second Primary, Prostatic Neoplasms, Testicular Neoplasms / secondaryAbstract
We describe the case of a 78- year- old man with metastatic hormone- sensitive prostate adenocarcinoma who was diagnosed with a metachronous right testicular seminoma during follow- up. He initially presented with low back pain, weight loss, and a PSA level of 909 ng/mL. Prostate biopsy revealed a Gleason 9 (4+5)(4+5) adenocarcinoma with extensive osseous metastases and pelvic and interatocoval nodal involvement. He initiated androgen deprivation therapy with leuprorelin (preceded by bicalutamide) combined with apalutamide, achieving good biochemical and clinical response.
At 12 months, progression of the interatocoval lymphadenopathy was observed, and he underwent palliative radiotherapy. At month 14, evaluation of right testicular enlargement revealed a mass subsequently confirmed as seminoma (pT1b, R0) following radical orchiectomy. Post- radiotherapy and post- orchiectomy computed tomography (CT) demonstrated significant regression of the retroperitoneal lymphadenopathy.
This case underscores the importance of considering second primary malignancies during prostate oncologic follow- up, particularly when new clinical findings are not fully explained by the underlying disease.
Downloads
References
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229-63. doi: 10.3322/ caac.21834. DOI: https://doi.org/10.3322/caac.21834
Raychaudhuri R, Lin DW, Montgomery RB. Prostate Cancer: A Review. JAMA. 2025;333:1433-46. doi: 10.1001/jama.2025.0228. DOI: https://doi.org/10.1001/jama.2025.0228
Berjaoui MB, Herrera-Caceres JO, Li T, Qaoud Y, Tiwari R, Ma D, et al. Age related differences in primary testicular lymphoma: A population based cohort study. Urol Oncol. 2023;41:151.e1-151.e10. doi: 10.1016/j.urolonc.2022.10.032. DOI: https://doi.org/10.1016/j.urolonc.2022.10.032
Secondino S, Rosti G, Tralongo AC, Nolè F, Alaimo D, Carminati O, et al. Testicular tumors in the "elderly" population. Front Oncol. 2022;12:972151. doi: 10.3389/fonc.2022.972151. DOI: https://doi.org/10.3389/fonc.2022.972151
Bubendorff L, Schöpfer A, Wagner U, Sauter G, Moch H, Willi N, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol. 2000;31:578-83. doi: 10.1053/hp.2000.6698. DOI: https://doi.org/10.1053/hp.2000.6698
Hermi A, Boussaffa H, Saadi A, Blei A, Chakroun M, Ben Slama MR. Prostate adenocarcinoma metastasis to the testis: A new case report. Urol Case Rep. 2023;48:102392. doi: 10.1016/j.eucr.2023.102392. DOI: https://doi.org/10.1016/j.eucr.2023.102392
Herrera Ortiz AF, Rojas J, Yepes MM, Quiroz Alfaro AJ. Isolated testicular metastasis in a patient with prostate cancer. BMJ Case Rep. 2024;17:e261274. doi: 10.1136/bcr-2024-261274. DOI: https://doi.org/10.1136/bcr-2024-261274
Gupta N, Dey S, Verma R, Belho ES. Isolated testicular metastasis from prostate cancer detected on Ga-68 PSMA PET/CT scan. Nucl Med Mol Imaging. 2020;54:319-23. doi: 10.1007/s13139-020-00673-4. DOI: https://doi.org/10.1007/s13139-020-00673-4
Weiberg D, Radner H, Derlin T, Thon WF. Early detection of bilateral testicular metastases from prostatic adenocarcinoma using 68Ga-PSMA ligand PET/CT. Clin Nucl Med. 2017;42:563-4. doi: 10.1097/RLU.0000000000001659. DOI: https://doi.org/10.1097/RLU.0000000000001659
Waisanen KM, Osumah T, Vaish SS. Testicular metastasis from prostatic adenocarcinoma presenting as recurrent epididymo-orchitis. Urology. 2017;108:e7-e9. doi: 10.1016/j.urology.2017.07.029.
de Oliveira Taveira M, Razmaria AA, Schoder H, Yeh R. Prostate cancer recurrence due to isolated testicular metastases detected by PSMA PET/CT. J Nucl Med. 2025;66:892-5. doi: 10.2967/jnumed.124.269361. DOI: https://doi.org/10.2967/jnumed.124.269361
Aggarwal P, Gupta K, Sood A, Bora GS, Goyal S, Singh H, et al. Simultaneous metastatic involvement of bilateral testes and left spermatic cord in prostate cancer detected on 68Ga-PSMA-11 PET/CT. Clin Nucl Med. 2024;49:e593-4. doi: 10.1097/RLU.0000000000005466. DOI: https://doi.org/10.1097/RLU.0000000000005466
Waisanen KM, Osumah T, Vaish SS. Testicular metastasis from prostatic adenocarcinoma presenting as recurrent epididymo-orchitis. Urology. 2017;108:e7-e9. doi: 10.1016/j.urology.2017.07.029. DOI: https://doi.org/10.1016/j.urology.2017.07.029
Zhang J, Dong M, Hu X, Liu L, Li S, Li C, et al. Prostatic adenocarcinoma presenting with metastases to the testis and epididymis: A case report. Oncol Lett. 2015;11:792-4. doi: 10.3892/ol.2015.3920. DOI: https://doi.org/10.3892/ol.2015.3920
Malkiewicz B, Swirkosz G, Lewandowski W, Demska K, Szczepaniak Z, Karwacki J, et al. Lymph node dissection in testicular cancer: The state of the art and future perspectives. Curr Oncol Rep. 2024;26:318-35. doi: 10.1007/s11912-024-01511-y. DOI: https://doi.org/10.1007/s11912-024-01511-y
Swanson GP, Hubbard JK. A better understanding of lymphatic drainage of the prostate with modern imaging and surgical techniques. Clin Genitourin Cancer. 2013;11:431-40. DOI: https://doi.org/10.1016/j.clgc.2013.04.031
Haupt HM, Mann RB, Trump DL, Abeloff MD. Metastatic carcinoma involving the testis: Clinical and pathologic distinction from primary testicular neoplasms. Cancer. 1984;54:709-14. doi:10.1002/1097-0142(1984)54:4<709::aidcncr2820540419>3.0. co;2-6. DOI: https://doi.org/10.1002/1097-0142(1984)54:4<709::AID-CNCR2820540419>3.0.CO;2-6
LaVigne AW, Doss VL, Berizzi D, Johnston FM, Kiess AP, Kirtane KS, et al. The history and future of multidisciplinary cancer care. Semin Radiat Oncol. 2024;34:441-51. doi: 10.1016/j.semradonc.2024.07.006. DOI: https://doi.org/10.1016/j.semradonc.2024.07.006
Downloads
Published
Issue
Section
License
Copyright (c) 2026 APU Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
